Literature DB >> 1504770

Serotonergic phase shifts of the mammalian circadian clock: effects of tetrodotoxin and high Mg2+.

R A Prosser1, H C Heller, J D Miller.   

Abstract

The mammalian circadian clock in the suprachiasmatic nuclei (SCN) can be phase-shifted in vitro by the serotonin agonist quipazine. Here we show that quipazine resets the SCN clock in the presence of tetrodotoxin or 10 mM Mg2+, treatments that block Na+ action potentials and Ca2+ channels, respectively. These results support the hypothesis that quipazine resets the clock by stimulating receptors located on clock elements rather than on cells afferent to the clock.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1504770     DOI: 10.1016/0006-8993(92)90784-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus.

Authors:  J C Ehlen; G H Grossman; J D Glass
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  Glutamate blocks serotonergic phase advances of the mammalian circadian pacemaker through AMPA and NMDA receptors.

Authors:  R A Prosser
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

3.  Circadian phase shifts to neuropeptide Y In vitro: cellular communication and signal transduction.

Authors:  S M Biello; D A Golombek; K M Schak; M E Harrington
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

4.  Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.

Authors:  V K Gribkoff; R L Pieschl; T A Wisialowski; A N van den Pol; F D Yocca
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.